26 oct
|
Alexion
|
Barcelona
Alexion, Astra Zeneca Rare Disease, seeks a Director for Integral Value Access and Pricing in Neurology to lead NMOSD strategy across EU markets. You will shape payer value propositions, HTA engagement, and lifecycle management with cross-functional partners to accelerate patient access for transformative therapies. The role combines strategic leadership in value communications, evidence planning, and market access execution, with broad visibility and international scope in a hybrid Barcelona-based #J-18808-Ljbffr
📌 Global Neurology Access Lead – Nmosd | Hybrid (Barcelona)
🏢 Alexion
📍 Barcelona